Materia licences metathesis catalyst pla
๐
Article
๐
2007
๐
Elsevier Science
โ 433 KB
## Materia licences metathesis catalyst platform to Aileron Therapeutics Materia Inc announced the licensing of its metathesis platform to Aileron Therapeutics, an emerging biopharmaceutical company, for use in the discovery and development of peptide therapeutics directed at intracellular protein-